Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy

Adam J Wolpaw1, Chi V Dang2

  • 1Divisions of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; The Wistar Institute, Philadelphia, PA 19104, USA.

Trends in Cell Biology
|December 13, 2017
PubMed

Insights

Targeting cancer metabolism is promising, but the tumor microenvironment and circadian rhythms complicate precision. This review highlights strategies for accurate cancer metabolism targeting.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Tumor microenvironment (TME)

Background:

  • Oncogenic drivers influence cancer cell metabolism, creating vulnerabilities.
  • Targeting cancer metabolism offers therapeutic potential.
  • Tumor microenvironment (TME) complexity and circadian metabolism pose challenges to precision targeting.

Purpose of the Study:

  • Review current progress in cancer metabolism and TME metabolism.
  • Highlight precise and accurate targeting strategies for cancer metabolism.

Main Methods:

  • Literature review of cancer metabolism research.
  • Analysis of TME metabolic interactions.
  • Exploration of circadian rhythm effects on cancer metabolism.

Main Results:

  • Established links between oncogenic drivers and metabolic dependencies in cancer.
  • Identified metabolic vulnerabilities exploitable for cancer therapy.
  • Discussed challenges posed by TME and circadian rhythms.
  • Highlighted potential for precise metabolic targeting.

Conclusions:

  • Despite complexities, accurate targeting of cancer metabolism is achievable.
  • Understanding TME and circadian metabolism is crucial for therapeutic precision.
  • Metabolic interventions represent a promising avenue for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K